id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2101252,335ff941-5072-4340-9c0b-3d0ef0a162d1,Q1,ALPHA ONE FOUNDATION,61675,ALPHA ONE FOUNDATION,2018,first_quarter,HCR,Alpha-1 Antitrypsin Deficiency Awareness,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-03-05T15:59:24.313000-05:00
2101259,5fc7aae5-0065-4fa4-8dc8-2d0fb978104a,1T,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,EAGLE PHARMACEUTICALS INC.,2018,first_quarter,HCR,Issues related to the FDA regulatory process for prescription drugs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,1,2018-03-08T17:11:53.580000-05:00
2101264,687fa869-c393-450c-8060-38e2a8fb870d,1T,CARMEN GROUP INCORPORATED,8316,THE REGENTS OF THE UNIVERSITY OF MICHIGAN,2018,first_quarter,HCR,340 B,"HOUSE OF REPRESENTATIVES,SENATE",15000,,0,1,2018-03-09T15:23:30.920000-05:00
2101273,a4e53b7e-28de-4478-9845-1b51fde8b3fc,Q1,EPILEPSY FOUNDATION,13723,EPILEPSY FOUNDATION,2018,first_quarter,HCR,"Health care reform, Medicare, Medicaid, access to care","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Equal Employment Opportunity Commission (EEOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,White House Office",,60000,0,0,2018-03-13T14:27:04.723000-04:00
2101276,be2ab9f4-976e-4f7a-8d59-a33df87a7d7e,1T,"CAPITOL ASSOCIATES, INC.",8101,PRINCETON WOUND CARE CENTER,2018,first_quarter,HCR,Use of hyperbaric oxygen therapy for treatment of PTSD and CTE,,10000,,0,1,2018-03-13T16:38:21.283000-04:00
2101286,d1fce72b-1e62-4112-a209-f7956b2eabb0,1T,IMPACT HEALTH POLICY PARTNERS,401104696,THORN RUN PARTNERS OBO COALITION FOR ORGAN DISTRIBUTION EQUITY (CODE) (INFORMAL),2018,first_quarter,HCR,Reforms to the system for distributing organs for transplant.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,1,2018-03-14T17:30:35.770000-04:00
2101291,03b952cc-e034-4dc0-83ce-26cc1e7783e4,Q1,HOSPICE COMPASSUS,401103527,HOSPICE COMPASSUS,2018,first_quarter,HCR,"Quality requirements for hospice, advanced illness and palliative care
Patient Choice and Quality Care Act","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",,60000,0,0,2018-03-17T09:18:41.300000-04:00
2101301,e4f46e5e-2026-4af1-b279-a09a439bc5a9,Q1,TIMMONS CONSULTING,400880576,PATIENT SERVICES INC.,2018,first_quarter,HCR,"Health care issues relating to services provided by charitable non-profit foundations.
HR 3976 ""Access to Marketplace Insurance Act""","HOUSE OF REPRESENTATIVES,SENATE",21600,,0,0,2018-03-20T15:10:55.150000-04:00
2101330,606b2c6d-4119-43c7-9f3a-e561e56f38e5,Q1,NATIONAL ADVOCACY CENTER OF THE SISTERS OF THE GOOD SHEPHERD,77993,CONFERENCE OF PROVINCIALS OF NORTH AMERICA,2018,first_quarter,HCR,End the death penalty.  Fully fund the Children's Health Insurance Program.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-03-23T17:48:39.200000-04:00
2101337,ee1d0e0e-ac34-4d7b-bc53-25df6f5faeb5,1T,SOCIETY FOR VASCULAR SURGERY,296715,SOCIETY FOR VASCULAR SURGERY,2018,first_quarter,HCR,"Supporting Independent Payment Advisory Board Repeal - H.R.849/S.260, Protecting Seniors' Access to Medicare Act and S.251, Protecting Medicare from Executive Action, enacted into law
Supporting Medical Liability Reform - H.R.1215, Protecting Access to Care Act
ACA Repeal and Replace - not supporting
Supporting H.R.4206, Medicare Care Coordination Improvement Act
Comments on FY 2018 Hospital Outpatient Prospective Payment System Final Rule submitted to CMS, the agency corrected placement of vascular ultrasound codes
Supporting H.R.2267, Resident Physician Shortage Reduction Act
Supporting H.R.1876/S.781 - Good Samaritan Health Professionals Act
Opposing Medicare Payment Advisory Commission's proposal to rebalance the physician fee schedule towards primary care
Following opioids legislation","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,80000,0,1,2018-03-26T09:58:38.153000-04:00
2101355,feb5ff9e-a989-4823-9bfb-6ee0d955357c,Q1,SOCIETY FOR VASCULAR SURGERY,296715,SOCIETY FOR VASCULAR SURGERY,2018,first_quarter,HCR,"Supporting Independent Payment Advisory Board Repeal - H.R.849/S.260, Protecting Seniors' Access to Medicare Act and S.251, Protecting Medicare from Executive Action, enacted into law
Supporting Medical Liability Reform - H.R.1215, Protecting Access to Care Act
ACA Repeal and Replace - not supporting
Supporting H.R.4206, Medicare Care Coordination Improvement Act
Comments on FY 2018 Hospital Outpatient Prospective Payment System Final Rule submitted to CMS, the agency corrected placement of vascular ultrasound codes
Supporting H.R.2267, Resident Physician Shortage Reduction Act
Supporting H.R.1876/S.781 - Good Samaritan Health Professionals Act
Opposing Medicare Payment Advisory Commission's proposal to rebalance the physician fee schedule towards primary care
Following opioids legislation","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,80000,0,0,2018-03-27T15:25:06.183000-04:00
2101356,0fac267e-0fa1-4a80-9ec0-c204cc99c7b3,Q1,DNV USA INC.,400488400,"DNV USA, INC.",2018,first_quarter,HCR,"Hospital Accreditation Process, responsive to House Energy and Commerce Committee Request","HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG)",,44614,0,0,2018-03-27T22:00:09.023000-04:00
2101404,a711335d-9ca4-4da1-9855-3536dfaf94a4,Q1,THE MICHAEL LEWAN COMPANY,22746,"UNITED CONCORDIA COMPANIES, INC.",2018,first_quarter,HCR,Repeal and Reform of the Affordable Care Act as it relates to Dental Insurance,"HOUSE OF REPRESENTATIVES,SENATE",25000,,0,0,2018-03-29T14:10:57.840000-04:00
2101415,e8c83741-acdf-4a44-94a5-a8db62923a5c,Q1,"OWENS-ILLINOIS, INC",49646,OWENS-ILLINOIS INC,2018,first_quarter,HCR,General health care policy issues,"Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,U.S. Trade Representative (USTR)",,200000,0,0,2018-03-29T15:22:01.447000-04:00
2101423,5451a265-b7b4-4b07-b1fb-601f56191fa9,Q1,ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS,400577734,ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS,2018,first_quarter,HCR,"National Drug Abuse Crisis and related bills.

42 CFR Part 2 - advocating to align 42 CFR Part 2 (substance use privacy regulations) with HIPAA to allow appropriate access to patient information that is essential for providing whole-person care. Advocating for the introduction of House and Senate legislation - the Overdose Prevention and Patient Safety Act, H.R. 3545, and the Protecting Jessica Grubb's Legacy Act, S. 1850.

Behavioral Health Information Technology, extending health information technology assistance eligibility to more mental health and substance use disorder professionals and facilities. Specifically H.R. 3331 and S. 1732, the Improving Access to Behavioral Health Information Technology Act.

Telehealth, reforming barriers to Medicare reimbursement. Specifically, the CONNECT for Health Act, S. 1016/H.R. 2556.

Medicare coverage of Mental Health Counselors and Marriage and Family Therapists - the Mental Health Access Improvement Act, H.R. 3032, and the Seniors Mental Health Access Improvement Act, S. 1879.

Mental Health Parity

Behavioral Health

Senate Finance Committee Chronic Care Reform in Medicare - S. 870, Creating High-Quality Results and Outcomes Necessary to Improve (CHRONIC) Care Act of 2017.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of,White House Office",,110000,0,0,2018-03-29T16:50:13.203000-04:00
2101444,b0755f7b-576f-4964-9f1b-523006a9e090,Q1,THE POTOMAC GROUP,31918,AMERICAN PSYCHOLOGICAL ASSOCIATION,2018,first_quarter,HCR,mental health issues,"HOUSE OF REPRESENTATIVES,SENATE",20475,,0,0,2018-03-30T11:14:15.027000-04:00
2101445,c63f8b9f-f4ce-401e-9654-a40afb6944c9,Q1,THE POTOMAC GROUP,31918,AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES INC (FORMERLY APAPO),2018,first_quarter,HCR,mental health issues,"HOUSE OF REPRESENTATIVES,SENATE",13650,,0,0,2018-03-30T11:17:17.260000-04:00
2101446,f51d4b1b-e63b-4aa3-8eae-1d1517f42c6f,Q1,THE POTOMAC GROUP,31918,WALGREENS,2018,first_quarter,HCR,monitor and lobby on issues relating to retail pharmacies.,"HOUSE OF REPRESENTATIVES,SENATE",23000,,0,0,2018-03-30T11:20:18.590000-04:00
2101448,4a4c203e-1268-45e3-ac72-c86f565855b2,Q1,AMERICAN VAPING ASSOCIATION,401104102,AMERICAN VAPING ASSOCIATION,2018,first_quarter,HCR,Health and financial benefits offered by electronic cigarettes and vapor products.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-03-30T11:32:21.553000-04:00
2101474,626bbb27-ba88-4401-b2ed-963a35871dee,Q1,ALAN REUTHER,400618875,UAW RETIREE MEDICAL BENEFITS TRUST,2018,first_quarter,HCR,"Implementation, Repeal and Replacement of ACA; Changes in Medicare Benefits and Financing; Tax on Cadillac Health Plans and Cap on Exclusion for ESI; Mid-year Changes in Drug Formulary; Medicare Advantage plans; Part D Plans; Drug Price measures; Chronic Care Act; funding bills; insurance market stabilization legislation; CHIP Reauthorization; Repeal of IPAB.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2018-04-01T14:45:43.793000-04:00
2101475,efb0b5c6-dff4-43b2-9829-f1661a862168,Q1,ALAN REUTHER,400618875,RETIREES OF THE GOODYEAR TIRE & RUBBER COMPANY HEALTH CARE TRUST,2018,first_quarter,HCR,"Implementation, Repeal and Replacement of ACA; Changes in Medicare Benefits and Financing; Tax on Cadillac Health Plans and Cap on Exclusion for ESI; Mid-year changes in drug formularies; Medicare Advantage plans; Part D plans; Chronic Care Act; funding bills; insurance market stabilization legislation; CHIP Reauthorization; Repeal of IPAB.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",7500,,0,0,2018-04-01T14:48:45.357000-04:00
2101476,6ba81b69-1de3-4741-848b-d97d35cccef2,Q1,ALAN REUTHER,400618875,UNITED STEELWORKERS,2018,first_quarter,HCR,"Implementation, Repeal and Replacement of ACA; Changes in Medicare Benefits and Financing; Tax on Cadillac Health Plans and Cap on Exclusion for ESI; Mid-year Changes in Drug Formularies; Medicare Advantage plans; Part D Plans; Chronic Care Act; funding bills; insurance market stabilization legislation; CHIP Reauthorization; IPAB repeal.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",7500,,0,0,2018-04-01T14:49:46.793000-04:00
2101489,5e59bb55-b261-4ce5-9ad5-34c1272171ae,Q1,CSA STRATEGY GROUP LLC (FORMERLY CSA STRATEGIES LLC),400428072,COORDINTAED CARE NETWORK,2018,first_quarter,HCR,Issues related to the 340B program,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-02T08:47:25.620000-04:00
2101492,819b7e17-06f9-42c0-8323-05ab793669f9,Q1,CSA STRATEGY GROUP LLC (FORMERLY CSA STRATEGIES LLC),400428072,GATEWAY HEALTH,2018,first_quarter,HCR,Issues related to Medicaid managed care,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-02T08:50:28.447000-04:00
2101521,9eef7ed2-a561-486d-821f-2d89de52ab83,Q1,AMERICANS FOR SAFE ACCESS,312714,AMERICANS FOR SAFE ACCESS,2018,first_quarter,HCR,Medical Cannabis,"Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,,0,0,2018-04-02T10:58:03.273000-04:00
2101528,9630f17c-2fdf-4f3c-b431-7e8e6543bc2a,Q1,ASSOCIATION OF MATURE AMERICAN CITIZENS,400482380,ASSOCIATION OF MATURE AMERICAN CITIZENS,2018,first_quarter,HCR,Healthcare reform solutions and legislation,"HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2018-04-02T11:38:08.230000-04:00
2101575,3b22e064-7818-4cd6-b6d4-af25ae3154b9,Q1,"GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC)",33124,EASTERN REGIONAL MEDICAL CENTER,2018,first_quarter,HCR,"The American Health Care Act
The Affordable Care Act 
The Exchange Rate
Reinsurance Fee Rates
Medicaid and Medicare Funding","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-04-02T12:54:53.287000-04:00
2101581,fb2566ad-1fd4-438f-b332-ea66d987d8e9,Q1,"GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC)",33124,MACULA VISION RESEARCH FOUNDATION,2018,first_quarter,HCR,"The Affordable Care Act
The American Health Care Act
Eye Disease Funding Opportunities 
NIH Funding 
FY18 Defense Appropriations Funding for Eye Research","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-02T12:58:59.523000-04:00
2101601,d56c2652-4ee5-47f7-a6b5-7e77ddcce66f,Q1,HOLLAND & KNIGHT LLP,18466,ST REGIS MOHAWK TRIBE,2018,first_quarter,HCR,Health care delivery; pharmaceutical pricing and ownership of patents.,"HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",100000,,0,0,2018-04-02T14:10:25.927000-04:00
2101606,8711fda7-414a-485b-bb4e-5fb195c4be78,Q1,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2018,first_quarter,HCR,"Implementation of 21st Century Cures regenerative medicine provisions; H.R. 2430, S. 204, Trickett Wendler Right to Try Act; other FDA-related issues.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-04-02T14:19:28.720000-04:00
2101607,f8f1c435-d277-4277-933e-b420086e1308,Q1,HOLLAND & KNIGHT LLP,18466,PROTECTING ACCESS TO PAIN RELIEF COALITION,2018,first_quarter,HCR,"Advocating for policy to ensure patient access to pain relief; H.R. 664, Stop OD Act of 2017; S.1554, Safer Prescribing of Controlled Substances Act; H.R. 3964, Opioid Addiction Prevention Act of 2017; H.R. 2063, Opioid PACE Act of 2017.","HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-04-02T14:22:30.077000-04:00
2101609,52145b37-f3d9-46b1-8056-f3b6548a53e9,Q1,HOLLAND & KNIGHT LLP,18466,TRUVEN HEALTH ANALYTICS,2018,first_quarter,HCR,Health Information Technology (HIT); official Medicare and Medicaid drug compendia for off-label uses; FDA draft guidance for mobile medical applications; federal fraud prevention initiatives.,,10000,,0,0,2018-04-02T14:25:32.280000-04:00
2101636,49bbacae-2eba-41ff-aed8-d59e905ad7fb,Q1,MR. C. TUCKER ANDERSON,401104294,"CODE 3 EMERGENCY PARTNERS, LLC",2018,first_quarter,HCR,Emergency Medicine,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-02T14:46:56.743000-04:00
2101650,c64acd63-c9d7-4f5c-8719-c1521863324a,Q1,HOLLAND & KNIGHT LLP,18466,TRIWEST HEALTHCARE ALLIANCE CORPORATION,2018,first_quarter,HCR,Veterans Choice Program authorization and appropriations.,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2018-04-02T14:58:06.223000-04:00
2101682,43abadd4-19c2-47bf-a86d-e09b9a1996dd,Q1,VAN FLEET ASSOCIATES,39781,MAXUS33,2018,first_quarter,HCR,Tracking pharmaceuticals throughout the supply chain,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-02T15:29:31.670000-04:00
2101688,5426f5dd-3c6a-4e11-8f82-88cdea487b6a,Q1,THE AMERICAN COUNCIL OF ENGINEERING COMPANIES,2046,AMERICAN COUNCIL OF ENGINEERING COMPANIES,2018,first_quarter,HCR,"PL 111-148, health care reform; repeal of employer mandates; HR 246, repeal of health insurance tax; HR 1101, association health plans, Labor Department proposed Association Health Plan rule.","Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Emergency Management Agency (FEMA),Federal Energy Regulatory Commission (FERC),Federal Highway Administration (FHA),Federal Transit Administration (FTA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA)",,706876,0,0,2018-04-02T16:14:39.390000-04:00
2101765,6736cab0-1b17-4797-8ebc-7041c21e7d11,Q1,MS. TAMI WAHL,401104405,ROCK & ASSOCIATES,2018,first_quarter,HCR,"Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-03T08:17:03.813000-04:00
2101783,fc0bd64e-3746-4aa0-9340-7c827e4cb5bc,Q1,"ROBERT N. PYLE & ASSOCIATES, INC.",32500,INDEPENDENT BAKERS ASSOCIATION,2018,first_quarter,HCR,"Health Care Cost, Prescription drugs","Agriculture, Dept of (USDA),Commodity Futures Trading Commission (CFTC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Energy Regulatory Commission (FERC),Federal Motor Carrier Safety Administration,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Highway Traffic Safety Administration (NHTSA),Occupational Safety & Health Administration (OSHA),Pension Benefit Guaranty Corporation (PBGC),SENATE,Transportation, Dept of (DOT),U.S. Trade Representative (USTR),White House Office",,,0,0,2018-04-03T09:56:14.553000-04:00
2101801,4e90d9f5-1bec-498e-b52f-99bed153d07d,Q1,ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC),4380,ASHLAND INC (PREVIOUSLY KNOWN AS ASHLAND LLC),2018,first_quarter,HCR,Sunscreen Innovation Act implementation.,"Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,127000,0,0,2018-04-03T10:06:25.127000-04:00
2101823,72f01f4b-118f-4651-ae58-773cc62fab61,Q1,NATIONAL ASSOCIATION OF STATE DIRECTORS OF SPECIAL EDUCATION,40006039,NATIONAL ASSOCIATION OF STATE DIRECTORS OF SPECIAL EDUCATION,2018,first_quarter,HCR,"Medicaid, Affordable Care Act, Any legislation containing Medicaid provisions","Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-03T10:50:40.913000-04:00
2101858,a6f7be35-ba4b-4e1e-a544-d23b83185d6d,1A,"STONY BROOK UNIVERSITY, SUNY STONY BROOK",319698,STONY BROOK UNIVERSITY SUNY STONY BROOK,2018,first_quarter,HCR,"1. Consolidated Appropriations Act, 2018 - H.R. 1625, lobbied in support of this bill
2. Lobbied in support of increased funding for National Institutes of Health (NIH) in FY19
3. Lobbied in support of Congress delaying cuts to Medicaid Disproportionate Share Hospital Payments
4. Lobbied in support of maintaining funding for 340B Drug Pricing program
5. Lobbied against proposed cuts to Graduate Medical Education (GME), Medicare and Medicaid","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-03T12:49:24.073000-04:00
2101865,0b14f98a-af53-4f62-aa8e-80c533091a51,Q1,HEALTHCARE SUPPLY CHAIN ASSOCIATION,401104107,HEALTHCARE SUPPLY CHAIN ASSOCIATION,2018,first_quarter,HCR,"Healthcare policy issues related to healthcare suppliers and providers, supporting the group purchasing organizations (""GPOs"") safe harbor, developing solutions to generic drug price spikes and drug shortages, and general education about GPOs and their value to healthcare.","HOUSE OF REPRESENTATIVES,SENATE",,170000,0,0,2018-04-03T13:05:25.663000-04:00
2101873,37d50b84-3035-4152-afee-ef3b9e7e2b8c,Q1,REDROCK GOVERNMENT RELATIONS,401104314,AMERICAN OSTEOPATHIC ASSOCIATION,2018,first_quarter,HCR,HR 2373 pertaining to accreditation of osteopathic residency training programs,"HOUSE OF REPRESENTATIVES,SENATE",32500,,0,0,2018-04-03T14:13:34.127000-04:00
2101910,838b14f8-6639-4bc9-a912-065b1fb346df,Q1,THE O TEAM LLC,400783359,AUTISM SPEAKS INC.,2018,first_quarter,HCR,"Issues related to Autism.
Higher Education Reauthorization Act.
Kevin and Avonte's Law.
Perkin's Act Reauthorization.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-04-03T16:03:10.020000-04:00
2101934,17c7eb04-cba4-4021-8d9d-24f21abfb221,Q1,CHANGE HEALTHCARE,401103788,CHANGE HEALTHCARE,2018,first_quarter,HCR,"care coordination; health IT; social determinants of health; reducing waste, fraud and abuse; consumer price transparency; value-based payments; interoperability","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",,,0,0,2018-04-03T17:01:29.567000-04:00
2101956,85b1d908-8466-4536-8cf4-95317c96b974,Q1,"DS2 GROUP, LLC",400694066,ROCHE DIAGNOSTICS,2018,first_quarter,HCR,"HR 3271, Protecting Access to Diabetes Supplies Act; Laboratory Developed Tests",HOUSE OF REPRESENTATIVES,20000,,0,0,2018-04-03T22:31:55.327000-04:00
2101986,bbccc215-2f25-4b98-87e6-175b6f660ec3,Q1,MILLER & WENHOLD CAPITOL STRATEGIES,307034,PROTECTSENIORS ORG,2018,first_quarter,HCR,"H.R. 2578, Protection of earned retiree healthcare benefits.","HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2018-04-04T10:35:50.120000-04:00
2101988,4dd5df5e-3ffd-4564-bcc2-69f5b03d4803,Q1,MILLER & WENHOLD CAPITOL STRATEGIES,307034,AMERICAN ASSOCIATION OF HEALTHCARE ADMINISTRATIVE MANAGEMENT,2018,first_quarter,HCR,"Changes to Medicare Observation Stay requirements (HR 1421 & S 568).
Changes to 340B drug program (HR 4392).","Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2018-04-04T10:41:50.837000-04:00
2102005,b2c6bd11-aa11-451c-8afd-4855c83a2669,Q1,MILLER & WENHOLD CAPITOL STRATEGIES,307034,"CAREPAYMENT TECHNOLIGIES, INC.",2018,first_quarter,HCR,HR 3920 - Medicare payment pilot program,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2018-04-04T10:54:05.880000-04:00
2102015,642d7e8e-5a90-45a8-8f41-ebf54d364838,Q1,MWR CONSULTING,401104301,UNITEDHEALTH GROUP,2018,first_quarter,HCR,ACA Reform; Medicare Advantage; Health Insurance Tax,"HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2018-04-04T11:20:13.403000-04:00
2102017,549be391-971d-419a-830d-4b0c4755d698,Q1,MWR CONSULTING,401104301,"HOLLISTER, INC.",2018,first_quarter,HCR,ACA Reform; America's Health Care Act,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",45000,,0,0,2018-04-04T11:24:14.950000-04:00
2102019,881c774b-1fff-4ebc-a9ec-dca34b11e495,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2018,first_quarter,HCR,Promote greater medication safety and more appropriate medication use through more active involvement of pharmacists in patient care.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,144981,0,0,2018-04-04T11:26:16.370000-04:00
2102081,23af33e9-2cfe-4f73-9f6a-540ca9546a7c,Q1,THE BRIGHTUP GROUP LLC,400419998,ASSOCIATION OF NUTRITION & FOODSERVICE PROFESSIONALS (FKA-DIETARY MANAGERS ASSN),2018,first_quarter,HCR,"CMS Final Rule ""Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities"" - Section 483.60 Food and Nutrition Services.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-04T14:03:22.703000-04:00
2102089,81bfc084-36f3-4739-aea1-e698688cdf9c,Q1,THE BRIGHTUP GROUP LLC,400419998,"MORRISSEY STRATEGIC PARTNERS, LLC",2018,first_quarter,HCR,"Small Business Health Fairness Act, H.R. 1101
Small Business Health Plans Act, S. 1818
Executive Order 13813 ""Promoting Healthcare Choice and Competition Across the United States""","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-04T14:34:29.570000-04:00
2102184,68e852e4-f302-4829-9097-9fd535929bf5,Q1,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",401103161,"UNIVERSITY OF MARYLAND, BALTIMORE (UMB)",2018,first_quarter,HCR,"Health care reform efforts, health care research funding, NIH funding - indirect costs, Ryan White funding, cancer center funding, nursing education and research funding, FDA innovation program funding, opioid addiction legislation","HOUSE OF REPRESENTATIVES,SENATE",,10000,0,0,2018-04-05T10:06:18.237000-04:00
2102187,7b3cf763-5b78-43a3-9631-487649a818ef,Q1,CURA STRATEGIES,401104679,MYOKARDIA,2018,first_quarter,HCR,"Dept. of Defense CDMRP, cardiomyopathy research and awareness","HOUSE OF REPRESENTATIVES,SENATE",7500,,0,0,2018-04-05T10:18:24.733000-04:00
2102188,e1309084-0f16-4511-a1e1-d7cacfe026b4,Q1,CURA STRATEGIES,401104679,CHILDREN'S CARDIOMYOPATHY FOUNDATION,2018,first_quarter,HCR,"DoD CDRMP, cardiomyopathy research and awareness","HOUSE OF REPRESENTATIVES,SENATE",7500,,0,0,2018-04-05T10:19:25.983000-04:00
2102190,1a12f456-f82b-4728-92a4-b44710c9305a,Q1,CURA STRATEGIES,401104679,MDXHEALTH,2018,first_quarter,HCR,Adoption of prostate cancer biomarkers with the VHA,"HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",20000,,0,0,2018-04-05T10:20:27.590000-04:00
2102198,3368bd29-3402-414a-8f93-5ceb17ef56d8,Q1,MEDICAL DEVICE MANUFACTURERS ASSOCIATION,24794,MEDICAL DEVICE MANUFACTURERS ASSOCIATION,2018,first_quarter,HCR,"Issues relating to Medical Device User Fee and Modernization Act, Issues relating to Group Purchasing Organizations, Issues relating to Physician Sunshine Act, Issues relating to Comparative Effectiveness, Issues relating to the FDA Globalization Act, Issues relating to SBIR, Issues relating to Gainsharing, Issues relating to Medical Device Tax","Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE",,300000,0,0,2018-04-05T10:44:33.460000-04:00
2102207,ce9f1225-ad12-4c29-a28e-58227082f3ad,Q1,"SLEEP, INC.",401104032,"SLEEP, INC.",2018,first_quarter,HCR,Issues related to general sleep health,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-05T11:21:44.717000-04:00
2102213,7e73d0f8-ce26-42ce-a4a0-fb3ef13518fb,Q1,COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE,11003,COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE,2018,first_quarter,HCR,"Support for H.R. 4710
Support for H.R. 4710
CCAGW Supports H.R. 4929- The Stopping Payments to Deceased People Act
CCAGW: Reject Any Effort to Change Pass-Through Payment Status for Biosimilars in Omnibus
CCAGW: Reject Any Effort to Change Pass-Through Payment Status for Biosimilars in Omnibus
CCAGW: Reject Any Effort to Change Pass-Through Payment Status for Biosimilars in Omnibus
CCAGW: Reject Any Effort to Change Pass-Through Payment Status for Biosimilars in Omnibus
CCAGW: Include Cole-Bishop Provision in Omnibus
CCAGW: Include Cole-Bishop Provision in Omnibus
CCAGW: Include Cole-Bishop Provision in Omnibus
CCAGW: Include Cole-Bishop Provision in Omnibus
CCAGW: Include Cole-Bishop Provision in Omnibus
CCAGW: Include Cole-Bishop Provision in Omnibus
CCAGW Supports S. 2312
Repeal IPAB: Support H.R. 849
CCAGW Supports S. 2374- The Stopping Payments to Deceased People Act
CCAGW: Reject Any Effort to Change Pass-Through Payment Status for Biosimilars in Omnibus
CCAGW: Reject Any Effort to Change Pass-Through Payment Status for Biosimilars in Omnibus","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2018-04-05T12:13:50.077000-04:00
2102264,1d890b3b-20f1-4043-a401-b35817603004,Q1,CAPITOL HILL ADVOCATES LLC,46084,AMERICAN ASSOCIATION OF RADON SCIENTISTS AND TECHNOLOGISTS,2018,first_quarter,HCR,"ADVANCE RADON NOTIFICATION, TESTING AND MITIGATION IN FEDERAL POLICY; SUPPORT AUTHORIZATIONS AND APPROPRIATIONS FOR GRANT FUNDING, EPA FUNDING FOR RADON MITIGATION ACTIVITIES, SUPPORT NATIONAL LAB FUNDING TO VERIFY ACCURATE RADON MEASUREMENT TOOLS/TESTING CHAMBER.","Centers For Disease Control & Prevention (CDC),Environmental Protection Agency (EPA),Federal Housing Finance Agency (FHFA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office",20000,,0,0,2018-04-05T15:39:31.477000-04:00
2102286,f056d193-120d-4b94-9c40-444797fce7e6,Q1,NATIONAL VENTURE CAPITAL ASSOCIATION,21687,NATIONAL VENTURE CAPITAL ASSOCIATION,2018,first_quarter,HCR,Drug pricing; proposals to create limited use pathways for certain drugs; CMS reimbursement policy.,"Centers For Medicare and Medicaid Services (CMS),Commodity Futures Trading Commission (CFTC),Federal Communications Commission (FCC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),Office of the Comptroller of the Currency (OCC),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office",,511423,0,0,2018-04-05T16:02:45.610000-04:00
2102296,74d45538-549a-4ec5-96d2-49f2f4f31921,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,"INTUIT, INC.",2018,first_quarter,HCR,Promote sound general health care policy,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-05T16:04:48.280000-04:00
2102316,de9b2792-cfaa-4861-9255-771cd0929f58,Q1,MCDERMOTT WILL & SCHULTE LLP,24338,TOTAL ADMINISTRATIVE SERVICES CORPORATION,2018,first_quarter,HCR,Efforts to improve and expand Health Reimbursement Arrangements (HRAs).,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Treasury, Dept of",20000,,0,0,2018-04-05T16:59:12.390000-04:00
2102340,9184927a-acae-4879-aaf8-e68cf567201f,1T,"CROSSROADS STRATEGIES, LLC",400531586,AIR LINE PILOTS ASSOCIATION,2018,first_quarter,HCR,"H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to health care coverage in the airline industry.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2018-04-05T20:26:37.400000-04:00
2102351,95364518-a789-4e03-8d82-eda75c631163,Q1,"CHATMAN, LLC",400678024,LIVINGSTON GROUP FOR RUSH UNIVERSITY MEDICAL CENTER,2018,first_quarter,HCR,340B HRSA Program,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-04-05T22:28:42.850000-04:00
2102354,00bd421e-658c-4693-9834-b8b4f4e031bb,Q1,"DEXCOM, INC.",401104564,"DEXCOM, INC.",2018,first_quarter,HCR,Coverage policy for therapeutic continuous glucose monitoring,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-06T07:58:52.250000-04:00
2102361,27f17cb2-c237-4f25-a7e6-c13ed6a64e76,1T,"UPSTREAM CONSULTING, INC.",88278,AEGERION PHARMACEUTICALS A NOVELION THERAPEUTICS COMPANY,2018,first_quarter,HCR,rare disease issues,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,1,2018-04-06T08:49:57.957000-04:00
2102374,d2f8c695-dd2b-4a02-82f9-a7bc7a2df3a7,Q1,INTERNATIONAL HEARING SOCIETY,401042933,INTERNATIONAL HEARING SOCIETY,2018,first_quarter,HCR,"Over the counter hearing aids, implementation of H.R. 2430
Support for H.Res. 740, March 3 at World Hearing Day","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES",,40000,0,0,2018-04-06T09:37:10.663000-04:00
2102377,70500b09-0cfa-4bda-b1b0-fe3690536b99,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,CLAIM YOUR HEALTH DATA COALITION,2018,first_quarter,HCR,Issues related to health IT and medical records.,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",50000,,0,0,2018-04-06T09:43:13.300000-04:00
2102379,4a2dd028-b8c7-4999-b70b-e1ac986767d2,Q1,MR. MICHAEL ROMANSKY,400418985,"OUTPATIENT OPHTHALMIC SURGERY SOCIETY, INC",2018,first_quarter,HCR,"Lobbying for fair reimbursement and reasonable quality reporting and regulatory requirements for ambulatory surgical centers. Lobbying for HR 1453 and S 2071, ""The ASC Quality and Access Act of 2015""","Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE",50000,,0,0,2018-04-06T09:46:14.737000-04:00
2102381,1482200c-d9e4-4994-8fbd-534347d4fd72,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,SSI GROUP,2018,first_quarter,HCR,Issues related to health IT and medical records,"Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,,0,0,2018-04-06T09:58:19.437000-04:00
2102390,134e7756-c857-47fe-899c-ee1b910e6c4a,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,JOHNSON & JOHNSON VISION,2018,first_quarter,HCR,Issues related to health care in the ophthalmology industry.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-06T10:07:27.593000-04:00
2102393,5ed353fa-5221-4103-a878-7db41293376e,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"ACELRX PHARMACEUTICALS, INC.",2018,first_quarter,HCR,FDA drug approval process,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-04-06T10:09:32.387000-04:00
2102395,5f7f6f6a-2a63-4aab-8d22-8d95f2eb98be,Q1,THE MCGRATH GROUP LLLC,401103940,"ALLSUP INC,",2018,first_quarter,HCR,Disability.,"HOUSE OF REPRESENTATIVES,SENATE",35000,,0,0,2018-04-06T10:10:33.577000-04:00
2102399,e910a76a-e69f-4ba8-aba8-609874d34e06,Q1,THE MCGRATH GROUP LLLC,401103940,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2018,first_quarter,HCR,Medicare and Medicaid eligibility and reimbursement;  Tricare; Provider Status; Drug Importation: Pharmaceutical products and services; H.R. 592 and S. 109 Pharmacy and Medically Underserved Areas Enhancement Act.,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2018-04-06T10:15:38.307000-04:00
2102405,3b892256-655d-4d61-aa8c-0a4181ebec2f,Q1,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,401103605,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,2018,first_quarter,HCR,"Lobbied for OTC Monograph Reform bill, answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the pharma/biopharma contract services sector.","HOUSE OF REPRESENTATIVES,SENATE",,50000,0,0,2018-04-06T10:18:42.090000-04:00
2102411,93e4cbeb-26fc-45fb-9be4-51d24d6e751f,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.",2018,first_quarter,HCR,Issues related to diabetes and cardiovascular disease and animal health issues,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2018-04-06T10:23:48.667000-04:00
2102416,a8024d19-792a-4330-a6dd-8d7ed89b0548,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"EMD SERONO, INC.",2018,first_quarter,HCR,Pharmaceutical issues,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-06T10:29:54.163000-04:00
2102418,560367ef-025f-4975-aab9-61777ecbd578,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,EXACT SCIENCES CORPORATION,2018,first_quarter,HCR,Issues related to repeal and replace of the Affordable Care Act,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-06T10:34:58.177000-04:00
2102422,cd59d3c6-0b00-4bc8-a6c7-00517945266f,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"SUMITOMO PHARMA CO., LTD. (FORMERLY SUNOVION PHARMACEUTICALS, INC.)",2018,first_quarter,HCR,Mental Health issues,"HOUSE OF REPRESENTATIVES,SENATE",51000,,0,0,2018-04-06T10:39:00.707000-04:00
2102425,99e45ce1-aa10-4763-98c3-f7cb098c067a,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"ACADIA HEALTHCARE, INC.",2018,first_quarter,HCR,Issues related to the opioid addiction epidemic,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2018-04-06T10:47:02.020000-04:00
2102426,7918aaab-6a6b-40f5-9ef0-f9577b97c9e2,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,BIODELIVERY SCIENCES INTERNATIONAL,2018,first_quarter,HCR,Issues related to the opioid addiction epidemic,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",40000,,0,0,2018-04-06T10:51:03.283000-04:00
2102430,16a9ec78-2bd3-49cc-bc29-b5d0953121ee,Q1,ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES,1728,ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES,2018,first_quarter,HCR,"Affordable Care Act
Medicaid","Education, Dept of,Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",,20000,0,0,2018-04-06T10:52:04.783000-04:00
2102434,c898b3fc-9264-4094-b854-53c2b060226f,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,HEALOGICS,2018,first_quarter,HCR,CHRONIC Care Act,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-06T10:53:05.470000-04:00
2102451,85294d98-5ec2-4493-be4a-2516440e2135,Q1,CENTER ROAD SOLUTIONS,401104751,EATING DISORDERS COALITION,2018,first_quarter,HCR,"P.L. 114-255 ""21st Century Cures Act,"" all provisions.  HR 1625/P.L. 115-141 ""Consolidated Appropriations Act, 2018,"" all provisions.  Issues pertaining to FY 2019 Labor, Health and Human Services, Education, and Related Agencies appropriations, all provisions.  S. Amdt. 2222 Bipartisan Health Care Stabilization Act of 2018'' to H.R. 1625 Consolidated Appropriations Act, 2018, all provisions.","Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of,White House Office",30000,,0,0,2018-04-06T12:06:28.813000-04:00
2102454,507032a0-9721-4d20-98d8-452aa14f6430,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.),2018,first_quarter,HCR,Health care coverage,"HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE",40000,,0,0,2018-04-06T12:47:35.777000-04:00
2102456,61092960-daf3-44d9-bde5-2014f1608bed,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)",2018,first_quarter,HCR,340B drug pricing program; policies and regulations impacting drugs for rare diseases and conditions,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2018-04-06T12:54:46.120000-04:00
2102458,41882172-f623-41c6-a195-b178e154850e,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"SPARK THERAPEUTICS, INC.",2018,first_quarter,HCR,Education regarding gene therapies/one-time treatments,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2018-04-06T12:57:48.713000-04:00
2102460,1d9c542d-7814-4a70-a3dd-8990674b3b47,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,OTTOBOCK HEALTHCARE LP,2018,first_quarter,HCR,H.R.2599/S.1191 - Medicare Orthotics and Prosthetics Improvement Act of 2017,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-06T13:00:25.140000-04:00
2102462,f6f8e0b1-d2c3-47cb-b0c0-3b1fb37f1d27,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,CARL ZEISS MEDITEC AG,2018,first_quarter,HCR,Issues related to health care in the ophthalmology industry.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2018-04-06T13:00:28.557000-04:00
2102466,6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,ASTELLAS PHARMA US,2018,first_quarter,HCR,Issues related to pharmaceutical pricing and NIH March In Rights,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2018-04-06T13:00:35.437000-04:00
2102471,ba301d1e-22df-43e9-947a-ed2363bb443f,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,"ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY",2018,first_quarter,HCR,DQSA implementation/drug compounding,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2018-04-06T13:06:51.570000-04:00
2102474,c1ea4561-717a-401f-8043-835abcffbf25,Q1,"JEFFREY J. KIMBELL & ASSOCIATES, INC.",46038,U.S. RENAL CARE,2018,first_quarter,HCR,"HR 3976, Access to Marketplace Insurance Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",50000,,0,0,2018-04-06T13:13:54.240000-04:00
2102483,d65beeba-4d31-4227-b939-4ba85785a3cd,Q1,I STREET ADVOCATES,51753,POST ACUTE AND LONG TERM CARE MEDICINE FORMERLY AMDA,2018,first_quarter,HCR,"S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017; changes to the Medicare advancing care information program for purposes of a long-term care setting; geriatrics workforce enhancement program funding; issues surrounding opioids","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-06T13:31:05.390000-04:00
2102493,56ec40b6-4e05-4ae3-b8b9-11c8891e7fed,Q1,I STREET ADVOCATES,51753,CHILDREN'S CAUSE FOR CANCER,2018,first_quarter,HCR,"H.R. 820/S. 292, The Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2017 or the Childhood Cancer STAR Act; issues surrounding fiscal year 2019 appropriations for NIH","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-06T13:34:08.157000-04:00
2102494,465317ab-4b87-456c-a2df-6e26b1c813d7,Q1,I STREET ADVOCATES,51753,SOCIETY OF TEACHERS OF FAMILY MEDICINE,2018,first_quarter,HCR,"S. 455, Restoring Rural Residencies Act; rural payment policy changes for physicians under graduate medical education; changes to policy under the Department of Veterans Affairs for rural family physician training programs; appropriations for the Agency for Healthcare Research and Quality and title 7 primary care funding under the Public Health Service Act","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-06T13:35:09.310000-04:00
2102495,3d88f378-a481-4dc1-989d-8082f2fce444,Q1,I STREET ADVOCATES,51753,USAGAINSTALZHEIMER'S,2018,first_quarter,HCR,S. 2387/H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act --legislation to provide better care and outcomes for Americans living with Alzheimer's disease and their caregivers while improving prevention strategies and disease modifying treatments.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2018-04-06T13:38:10.497000-04:00
2102507,a31e9579-befa-4e13-8edc-29120d4b4892,Q1,RED+BLUE STRATEGIES,400693064,EXPRESS SCRIPTS INC.,2018,first_quarter,HCR,"H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to access to and affordability of prescription medications and inclusion of tools to fight the opioid epidemic. 

H.R. 1301/PL 115-124 - Continuing Resolution of 2018 - Issues related to access to and affordability of prescription medications and policies and resources to fight the opioid crisis in the United States. 

CMS regulations related to the Medicare Part D program and role of Prescription Drug Plans. 

S. 637 - Creating Transparency to have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices.

S. 771 - A bill to Improve Access to Affordable Prescription Drugs - Issue related to bringing drug pricing down including better policies in the Part D coverage gap, couponing and advancing biosimilars. 

H.R. 281- National Defense Authorization Act for FY 2018- Issues related to prescription medications for military personnel and their families. 

H.R. 3447 - Furthering Access to Coordinated Treatment for Seniors (FACTS) Act of 2017 - Working to explain the need for safe and confidential data sharing between Medicare part A, B, and D to ensure better coordination of patient care.

Issues related to Direct and Indirect Renumeration policies and their impact on consumers. 

Issues related to the price of prescription medications in the United States.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2018-04-06T14:05:22.117000-04:00